8-KThe WireRoutine
Shareholder Vote
Filed Dec 29, 2022 · 3y ago · Accession 0001575872-22-001373
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Dec 29, 2022
- Report date
- Dec 22, 2022
- Document
- uptd-20221222.htm
- Size
- 271 KB